Navigating choice in multiple sclerosis management

Ralf A. Linker, Andrew Chan

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Background: With the advent of modern immunotherapies for relapsing-remitting multiple sclerosis (RRMS) and the increasing amount of treatment options on the market, MS has evolved as a treatable disease. Yet, at the same time, new challenges for the treating neurologists arise. Main body: This review article covers some of these challenges, including when and how to start treatment, treatment monitoring, and finally considerations on what the increasing choice in treatment options brings to disease management and longer-term planning. Among others, these important issues comprise pregnancy, treatment sequencing, switching or even stopping treatment. Conclusion: The ultimate goal for navigating choices in RRMS management is to choose the right drug for the right patient at the right time Throughout the article, there is a strong focus on practical aspects and individual decision making in MS to meet the concept of personalized medicine.

Original languageEnglish
Article number5
JournalNeurological Research and Practice
Issue number1
DOIs
StatePublished - 2019
Externally publishedYes

Keywords

  • Disease management
  • Immunomodulation
  • MS therapy
  • Personalized medicine
  • Treatment monitoring

Cite this